ALMSALUMIS INC.
Health Care
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents revised up 0.7% for Q1 2024
This is the 6th largest revision in ALMS's history.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Q1 2024
As reported
$169.5MRestated
$170.6M0.7%
Verify against SEC filingsShow
As reported$169.5M
Accepted 2025-05-140001847367-25-000028
Restated$170.6M
Accepted 2026-05-140001847367-26-000010
CashAndEquivalents · reported 3 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get an alert the next time ALMS — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.